DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Oldenburg J, Goudemand J, Valentino L , et al.
Postauthorization safety surveillance of ADVATE [antihaemophilic factor (recombinant), plasma/albumin-free method] demonstrates efficacy, safety and low-risk for immunogenicity in routine clinical practice.
Haemophilia 2010;
16 (6) 866-877
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.